G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.
about
Subversion of Host Innate Immunity by Uropathogenic Escherichia coliMacrophages Subvert Adaptive Immunity to Urinary Tract InfectionEarly severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infectionUrinary Tract Infection: Pathogenesis and Outlook.Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coliWaging war against uropathogenic Escherichia coli: winning back the urinary tractThe innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infectionCharacterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence.Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections.Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitisHuman bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli.Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.Monocyte trafficking in acute and chronic inflammation.Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityInhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL-1β-dependent mannerInduction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Androgens Enhance Male Urinary Tract Infection Severity in a New ModelThe co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions.Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatmentThe cytochrome bd-I respiratory oxidase augments survival of multidrug-resistant Escherichia coli during infection.Macrophagic control of the response to uropathogenic E. coli infection by regulation of iron retention in an IL-6-dependent manner.Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.Model systems for the study of Enterococcal colonization and infection.Urothelial generation and regeneration in development, injury, and cancer.Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis.Enterococcus faecalis promotes innate immune suppression and polymicrobial catheter-associated urinary tract infection.Vitamin D-deficient mice have more invasive urinary tract infection.Detection of intracellular bacteria in exfoliated urothelial cells from women with urge incontinence.Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.A novel ex vivo set-up for dynamic long-term characterization of processes on mucosal interfaces by confocal imaging and simultaneous cytokine measurements.The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.Male kidney allograft recipients at risk for urinary tract infection?
P2860
Q26770272-EECEA053-5D3A-4C14-9798-4414024F408EQ27318440-3181768D-17A5-4C6D-A60D-EE06BA5E66D5Q28475353-3BA78138-CE8D-4927-8914-E6C7BF88A047Q30244953-9CDD2072-8D0D-4F2D-938B-4119CF3524EAQ30499366-E24460F0-E9B0-4924-8904-9964B08E65C4Q33613902-1267CAE9-90BB-41E1-8F15-64FC9B3C00E3Q33652449-A2C15DD0-A86C-47EF-A999-45911E7A87B3Q33826150-8BBBBA8E-EF87-4B1D-8ADC-5755DE4EB794Q34177412-F9BFD6C4-2844-4D93-BDF5-2820FA0AE474Q34217562-6EF4EBCE-25EB-4607-9FB6-AE70D465B4F3Q35025542-0C046C33-5FBC-403F-8E99-1C3F18FD73A5Q35195313-D86401CA-05C8-41F0-A887-1C441238154DQ35230750-E78470D6-CD4B-4FD0-8BA7-1928C9059A24Q35273075-6435C660-6632-4A0B-A7A9-E777E7A038D9Q35646813-8B0F3C6D-66C5-4975-8391-54E0280C2570Q35677483-A2EA9C82-C27C-48CB-B5BC-652CB336D60DQ35687994-4D82A5D9-7885-4D1D-9616-2446DC997FC5Q35941046-D6C22D5A-C96B-4045-89CD-7FCA05D27F66Q36154064-9E40864F-5FCC-4625-9E3C-499907681D04Q36163174-169772BF-9224-415E-BFCC-01D2549C699AQ36506189-8EF31CF5-EFF3-4216-A7FA-6B79C6F75F0FQ36728035-D7B80B22-4979-4E7A-BC88-FA3A79634FA8Q36910650-700AF4C9-3D8D-444C-A1F6-FCB6FFCC51EBQ36944667-56E10E98-7993-4B85-A1E1-21633AE1AA6FQ37107107-31ECDC84-F8AE-4C71-8116-38388BB83273Q37277028-AF964303-4259-4477-B024-56CE29A13C64Q37355515-6BCEE166-EFEB-4F4D-B3E1-84790F35A625Q37467621-30F685FB-681A-412C-A648-17E6B8C7DA2DQ37478977-04EF1E43-0D66-4AC0-B734-71A00E06003EQ38142595-5DC8F3F0-47EA-43DB-9785-02313A92DE81Q38768532-76424376-D8DB-433F-B6A2-3BF5C6B48511Q39097235-0D476FF1-E538-45FC-8A67-19F5C59C4E33Q39647186-D29E807F-528A-499B-9490-8E0E0A113579Q40052544-C804B766-8616-4BB1-948A-51D4B5CE5047Q40117068-6BB4B3B6-33D7-47E6-B0BC-DD32E1B6C2C4Q40617412-E71A926B-513C-47DB-91E1-A3EBC97179B1Q41022801-4CB40A80-6EAD-4577-8168-876D757DE1B9Q42486802-040CCFDE-610C-4560-AE32-3CDFC048F968Q45344331-5F901C45-2FDF-4B63-A609-7DBABADBCEB1Q47100042-ADB2FDF5-1C65-417A-ADC3-135AD1BD63D3
P2860
G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
G-CSF induction early in uropa ...... tract modulates host immunity.
@ast
G-CSF induction early in uropa ...... tract modulates host immunity.
@en
G-CSF induction early in uropa ...... tract modulates host immunity.
@nl
type
label
G-CSF induction early in uropa ...... tract modulates host immunity.
@ast
G-CSF induction early in uropa ...... tract modulates host immunity.
@en
G-CSF induction early in uropa ...... tract modulates host immunity.
@nl
prefLabel
G-CSF induction early in uropa ...... tract modulates host immunity.
@ast
G-CSF induction early in uropa ...... tract modulates host immunity.
@en
G-CSF induction early in uropa ...... tract modulates host immunity.
@nl
P2093
P2860
P1476
G-CSF induction early in uropa ...... tract modulates host immunity
@en
P2093
Hailyn V Nielsen
Molly A Ingersoll
Scott J Hultgren
P2860
P304
P356
10.1111/J.1462-5822.2008.01230.X
P577
2008-08-26T00:00:00Z